<b>Conclusions</b>: Serum CHI3L1 is positively associated with established markers of inflammation and may serve as a useful non-invasive biomarker for monitoring IBD activity during pregnancy, a medical condition in which invasive procedures are not recommended. Here, CHI3L1 is linked to inflammatory bowel disease.